MONOPAR THERAPEUTICS INC (MNPR)
US61023L1089 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to MNPR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.04. This target is 210.5% above the current price.
MNPR was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about MNPR.
In the previous month the buy percentage consensus was at a similar level.
MNPR was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-11 | JonesTrading | Upgrade | Hold -> Buy |
| 2023-06-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-29 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-03-28 | EF Hutton | Maintains | Buy |
| 2023-03-24 | EF Hutton | Reiterate | Buy |
| 2023-02-15 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-14 | EF Hutton | Reiterate | Buy |
| 2023-01-23 | EF Hutton | Initiate | Buy |
| 2022-12-09 | Roth Capital | Reiterate | Buy |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-01 | HC Wainwright & Co. | Initiate | Buy |